ITEMS IN AFP WITH KEYWORD:
Oct 15, 2015 Issue
ACIP Releases Recommendations for Influenza Vaccination, 2015-2016 [Practice Guidelines]
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) has released its yearly recommendations for routine influenza vaccination in the 2015–2016 season.
New guidelines in pneumococcal immunization policy reflect evidence for the expansion of PCV13 to persons older than 65 years and to some high-risk younger adults, and afford the opportunity to improve the health of adults.
Recommendations for several vaccinations have changed in recent years. Find out the latest on these vaccines: pneumococcal conjugate; rotavirus; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap); meningococcal; influenza; and human papillomavirus.
Family physicians have an opportunity to significantly reduce rates of cervical and oropharyngeal cancers with a safe and effective HPV vaccine. We should listen and address parental concerns, but also strongly recommend all childhood immunizations and use every opportunity to administer them.
A new 9-valent HPV vaccine is generally similar in effectiveness to the older quadrivalent vaccine. There is a small benefit of the new vaccine compared with the older vaccine for women who are initially uninfected (2.4 vs. 4.2 cases per 1,000 person-years), but you would have to immunize approximat...
Feb 15, 2015 Issue
ACIP Releases 2015 Childhood Immunization Schedules [Practice Guidelines]
The 2015 immunization schedule for children and the catch-up schedule from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) have a few changes that are pertinent for family physicians.
The 2015 adult immunization schedule from the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) has a few changes that are particularly relevant to family physicians.
Dec 15, 2014 Issue
AAP Issues Updated Guidance on Palivizumab Prophylaxis for RSV Infection [Practice Guidelines]
The American Academy of Pediatrics (AAP) Committee on Infectious Diseases has updated its guidance on the use of palivizumab (Synagis) prophylaxis in infants and children at increased risk of respiratory syncytial virus (RSV) infection. Because the palivizumab package labeling does not include a def...
High-dose influenza vaccine provided a 25% relative reduction in the likelihood of developing laboratory-confirmed influenza compared with standard-dose vaccine in patients 65 years and older. This corresponds to a number needed to treat of approximately 220 to prevent a laboratory-confirmed case of...
Nov 1, 2014 Issue
IDSA Releases Recommendations on Vaccinations in Immunocompromised Patients [Practice Guidelines]
Recommended vaccination schedules for immunocompetent children and adults are published annually by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention. Vaccination of immunocompromised patients is important because impaired host defenses predisp...